87 related articles for article (PubMed ID: 1525791)
1. Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia.
Casali L; Voi M; Janssen CJ; Olovich KG; Dere WH
Clin Ther; 1992; 14(4):570-7. PubMed ID: 1525791
[TBL] [Abstract][Full Text] [Related]
2. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
Alanis A; Longest KA; Senetar JE; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
[TBL] [Abstract][Full Text] [Related]
3. Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis.
Derriennic M; Voi M; Thoren LM; Black SA; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S43-6; discussion S46-8. PubMed ID: 1287618
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice.
Tilyard MW; Dovey SM
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):97S-101S. PubMed ID: 1617932
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cefaclor AF in the treatment of skin and skin-structure infections.
Schupbach CW; Olovich KG; Dere WH
Clin Ther; 1992; 14(3):470-9. PubMed ID: 1638588
[TBL] [Abstract][Full Text] [Related]
6. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
Hyslop DL; Bischoff W
Am J Med; 1992 Jun; 92(6A):86S-94S. PubMed ID: 1621752
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
Drehobl M; Bianchi P; Keyserling CH; Tack KJ; Griffin TJ
Antimicrob Agents Chemother; 1997 Jul; 41(7):1579-83. PubMed ID: 9210689
[TBL] [Abstract][Full Text] [Related]
8. Cefaclor AF: correlation of microbiology and clinical outcome.
Thornsberry C
Postgrad Med J; 1992; 68 Suppl 3():S10-6. PubMed ID: 1287612
[TBL] [Abstract][Full Text] [Related]
9. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis.
Grossman RF
Postgrad Med J; 1992; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616
[TBL] [Abstract][Full Text] [Related]
10. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
McCarty J; Ruoff GE; Jacobson KD
Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
[TBL] [Abstract][Full Text] [Related]
11. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
[TBL] [Abstract][Full Text] [Related]
12. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study.
Donowitz GR; Brandon ML; Salisbury JP; Harman CP; Tipping DM; Urick AE; Talbot GH
Clin Ther; 1997; 19(5):936-53. PubMed ID: 9385482
[TBL] [Abstract][Full Text] [Related]
13. Comparative trials of cefaclor AF in uncomplicated cystitis and asymptomatic bacteriuria.
Hamilton-Miller JM; Iravani A; Brumfitt W; Byers KS; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S60-6; discussion S66-7. PubMed ID: 1287620
[TBL] [Abstract][Full Text] [Related]
14. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
15. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
Mogabgab WJ; Pollock B; Beville RB; Gentry LO; Jemsek JG
Postgrad Med J; 1979; 55 Suppl 4():62-6. PubMed ID: 44908
[TBL] [Abstract][Full Text] [Related]
17. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
Hyslop DL; Jacobson K; Guerra FJ
Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
Oizumi K; Watanabe A; Saito A; Tomizawa M; Nakayama I; Hiraga Y; Ohmichi M; Tamura M; Konishi K; Gomi K
Jpn J Antibiot; 1990 Nov; 43(11):1914-47. PubMed ID: 2287058
[TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
Piippo T; Stefansson S; Pitkäjärvi T; Lundberg C
Scand J Infect Dis; 1991; 23(4):459-65. PubMed ID: 1957129
[TBL] [Abstract][Full Text] [Related]
20. [Cephalosporin treatment of maxillary sinusitis].
Köhler W; Schenk P
Laryngorhinootologie; 1995 Jun; 74(6):355-60. PubMed ID: 7662079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
